KI

Healthcare · Pharmaceuticals

Kilitch Drugs (India) Ltd (KILITCH)

₹221.00

Mkt cap
₹790 Cr
P/E ratio
32.80
P/B
2.68
Div yield
0.00%
ROE
10.60%
ROCE
13.40%
EPS (TTM)
₹6.74
Book value
₹83
52W range
117–268
Sector
Healthcare

Price history

Previous close

Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products [1]

NSE KILITCHBSE 524500
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsBullish
52-week range
−17.51% from high
₹221
₹117+88.49% from low₹268
Current
₹221.00
Prev close
₹236.95
Day
−6.73%
Price performance
1D
−6.73%
1W
+2.74%
1M
+9.35%
3M
+35.97%
6M
+20.73%
1Y
+23.00%
YTD
+22.64%

Financials

Revenue, profit & margin
P/E ratio
32.8×
KILITCH is 1% above the sector median of 32.5×
KILITCH32.8×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales41.2031.7944.8233.4547.4756.1761.2343.1448.9253.8189.6044.8850.22
YoY Sales growth+34.20%+6.07%-1.45%-8.51%+15.22%+76.69%+36.61%+28.97%+3.05%-4.20%+46.33%+4.03%+2.66%
Expenses32.5829.5137.7431.7941.3747.4446.6439.8843.8847.6667.4641.9443.53
Operating Profit8.622.287.081.666.108.7314.593.265.046.1522.142.946.69
OPM %20.92%7.17%15.80%4.96%12.85%15.54%23.83%7.56%10.30%11.43%24.71%6.55%13.32%
Other Income0.492.960.472.575.161.731.702.566.661.530.492.902.16
Interest1.511.601.321.730.311.401.601.531.441.151.440.881.69
Depreciation0.820.810.930.850.610.810.850.840.860.940.981.093.82
Profit before tax6.782.835.301.6510.348.2513.843.459.405.5920.213.873.34
Tax %24.93%38.16%30.57%93.33%16.73%32.00%26.23%34.49%14.47%22.90%26.37%48.84%57.49%
Net Profit5.091.743.680.118.615.6110.222.278.044.3114.881.961.42
EPS in Rs1.440.881.090.412.621.813.160.922.341.274.150.830.64
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −1.15% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast13 Aug '26◦6 Nov '26◦
Earnings day−5.00%+2.71%
+1 day−9.75%+1.21%
+5 days−15.11%+25.05%
+15 days−5.37%—
+30 days+13.51%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
63.77%Promoter
Promoters63.77%
FIIs0.10%0.02
DIIs0.50%0.50
Public35.62%0.49
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Kilitch Drugs₹223.8132.807900.00%1−72.77%50+2.66%13.43%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings